AxoGen Q3 Revenue USD 75.8 Million Vs. IBES Estimate USD 73.2 Million
Oct 28 (Reuters) - AxoGen Q3 adjusted net income USD 13.1 million.
- Q3 adjusted EBITDA USD 13.4 million
- Q3 gross margin 74.8%
- Q3 net income USD 2.3 million
- outlook FY revenue USD 290 million vs. IBES estimate USD 283.2 million